Pharmaceuticals in Canadian sewage treatment plant effluents and surface waters: occurrence and environmental risk assessment

References

• Daughton CG, Ternes TA. Pharmaceuticals and personal care products in the environment: agents of subtle change? Environ Health Perspect. 1999;107(Suppl 6):907–938. doi: 10.1289/ehp.99107s6907
   PubMed Web of Science ®Google Scholar
• Robinson I, Junqua G, Van Coillie R, Thomas O. Trends in the detection of pharmaceutical products, and their impact and mitigation in water and wastewater in North America. Anal Bioanal Chem. 2007;387:1143–1151. doi: 10.1007/s00216-006-0951-y
   Google Scholar
• Hua WY, Bennett ER, Maio XS, Metcalfe CD, Letcher RJ. Seasonality effects on pharmaceuticals and s-triazine herbicides in wastewater effluent and surface water from the Canadian side of the upper Detroit River. Environ Toxicol Chem. 2006;25:2356–2365. doi: 10.1897/05-571R.1
   PubMed Web of Science ®Google Scholar
• Metcalfe CD, Koenig BG, Bennie DT, Servos M, Ternes TA, Hirsch R. Occurrence of neutral and acidic drugs in the effluents of Canadian sewage treatment plants. Environ Toxicol Chem. 2003;22:2872–2880. doi: 10.1897/02-469
   PubMed Web of Science ®Google Scholar
• Metcalfe CD, Miao XS, Koenig BG, Struger J. Distribution of acidic and neutral drugs in surface waters near sewage treatment plants in the lower Great Lakes, Canada. Environ Toxicol Chem. 2003;22:2881–2889. doi: 10.1897/02-627
   PubMed Web of Science ®Google Scholar
• Servos MR, Smith M, McInnis R, Burnison BK, Lee B, Seto P, Backus S. The presence of selected pharmaceuticals and the antimicrobial triclosan in drinking water in Ontario, Canada. Water Qual Res J Can 2007;42:130–137.
   Web of Science ®Google Scholar
• Brun GL, Bernier M, Losier R, Doe K, Jackman P, Lee HB. Pharmaceutically active compounds in Atlantic Canadian sewage treatment plant effluents and receiving waters, and potential for environmental effects as measured by acute and chronic aquatic toxicity. Environ Toxicol Chem. 2006;25:2163–2176. doi: 10.1897/05-426R.1
   PubMed Web of Science ®Google Scholar
• Carballa M, Omil F, Lema JM, Llompart M, Garcia-Jares C, Rodriguez I, Gomez M, Ternes T. Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Res. 2004;38:2918–2926. doi: 10.1016/j.watres.2004.03.029
   PubMed Web of Science ®Google Scholar
• Chen M, Ohman K, Metcalfe C, Ikonomou MG, Amatya PL, Wilson J. Pharmaceuticals and endocrine disruptors in wastewater treatment effluents and in the water supply system of Calgary, Alberta, Canada. Water Qual Res J Can. 2006;41:351–364.
   Web of Science ®Google Scholar
• Gagne F, Blaise C, Andre C. Occurrence of pharmaceutical products in a municipal effluent and toxicity to rainbow trout (Oncorhynchus mykiss) hepatocytes. Ecotoxicol Environ Saf. 2006;64:329–336. doi: 10.1016/j.ecoenv.2005.04.004
   PubMed Web of Science ®Google Scholar
• Heberer T, Reddersen K. Occurrence and fate of pharmaceuticals residues in the aquatic system of Berlin as an example for urban ecosystems. Second International Conference on Pharmaceuticals and Endocrine Disrupting Chemicals in Water; October 9–11. Minneapolis (MN): National Ground Water Association; 2001.
   Google Scholar
• Heberer T. Tracking persistent pharmaceuticals residues from municipal sewage to drinking water. J Hydrol. 2002;266:175–189. doi: 10.1016/S0022-1694(02)00165-8
   Web of Science ®Google Scholar
• Servos MR, Bennie DT, Starodub ME, Orr JC. Pharmaceuticals and personal care products in the environment: a summary of published literature. Burlington/Saskatoon: Environment Canada, National Water Research Institute; 2002.
   Google Scholar
• Ternes TA. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 1998;32:3245–3260. doi: 10.1016/S0043-1354(98)00099-2
   Web of Science ®Google Scholar
• Crane M, Watts C, Boucard T. Chronic aquatic environmental risks from exposure to human pharmaceuticals. Sci Total Environ. 2006;367:23–41. doi: 10.1016/j.scitotenv.2006.04.010
   PubMed Web of Science ®Google Scholar
• Flaherty CM, Dodson SI. Effects of pharmaceuticals on Daphnia survival, growth, and reproduction. Chemosphere. 2005;61:200–207. doi: 10.1016/j.chemosphere.2005.02.016
   PubMed Web of Science ®Google Scholar
• Parrott JL. Pharmaceuticals and personal care products in the Canadian environment. Environment Canada Workshop on the Effects of Pharmaceuticals and Personal Care Products in the Environment, PowerPoint Presentation; 2006.
   Google Scholar
• Parrott JL, Blunt BR. Life-cycle exposure of fathead minnows (Pimephales promelas) to an ethinylestradiol concentration below 1 ng/L reduces egg fertilization success and demasculinizes males. Environ Toxicol. 2005;20:131–141. doi: 10.1002/tox.20087
   PubMed Web of Science ®Google Scholar
• Pomati F, Orlandi C, Clerici M, Luciani F, Zuccato E. Effects and interactions in an environmentally relevant mixture of pharmaceuticals. Toxicol Sci. 2008;102:129–137. doi: 10.1093/toxsci/kfm291
   PubMed Web of Science ®Google Scholar
• Santos LH, Araujo AN, Fachini A, Pena A, Delerue-Matos C, Montenegro MC. Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment. J Hazard Mater. 2010;175:45–95. doi: 10.1016/j.jhazmat.2009.10.100
   PubMed Web of Science ®Google Scholar
• Stackelberg PE, Furlong ET, Meyer MT, Zaugg SD, Henderson AK, Reissman DB. Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant. Sci Total Environ. 2004;329:99–113. doi: 10.1016/j.scitotenv.2004.03.015
   PubMed Web of Science ®Google Scholar
• Kolpin DW, Furlong ET, Meyer MT, Thurman EM, Zaugg SD, Barber LB, Buxton HT. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999–2000: a national reconnaissance. Environ Sci Technol. 2002;36:1202–1211. doi: 10.1021/es011055j
   PubMed Web of Science ®Google Scholar
• Metcalfe CD, Miao XS, Hua W, Letcher R, Servos MR. Pharmaceuticals in the Canadian environment. In: Kümmerer K, editor. Pharmaceuticals in the environment: sources, fate, effects, and risks. Berlin: Springer; 2004. p. 67–90.
   Google Scholar
• Kleywegt S, Smyth S, Parrott J, Schaefer K, Lagacé E, Payne M, Topp E, Beck A, McLaughlin A, Ostapyk K. Pharmaceuticals and personal care products in the Canadian environment: research and policy directions. In: NWRI Scientific Assessment Report Series No. 8; 2007. p. 53.
   Google Scholar
• Arksey H, O'Malley L. Scoping studies: towards a methodological framework. Int J Social Res Method. 2005;8:19–32. doi: 10.1080/1364557032000119616
   Google Scholar
• Pawson R. Evidence-based policy: in search of a method. Evaluation. 2002;8:157–181.
   Google Scholar
• Bound JP, Voulvoulis N. Pharmaceuticals in the aquatic environment – a comparison of risk assessment strategies. Chemosphere. 2004;56:1143–1155. doi: 10.1016/j.chemosphere.2004.05.010
   PubMed Web of Science ®Google Scholar
• EMEA. Note for guidance on environmental risk assessment of medicinal products for human use, CPNP/SWP/4447/00 draft corr. London: European Agency for the Evaluation of Medicinal Products; 2005.
   Google Scholar
• Santos JL, Aparicio I, Alonso E. Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville City (Spain). Environ Int. 2007;33:596–601.
   Google Scholar
• E.A.f.t.E.o.M.P. (EAEMP). Draft CPMP discussion paper on environmental risk assessment of non-genetically modified organisms (non-GMO) containing medicinal products for human use, CPMP/SWP/4447/00. London: European Agency for the Evaluation of Medical Products (EAEMP); 2001.
   Google Scholar
• Fazio S, Linton MF. The role of fibrates in managing hyperlipidemia: mechanisms of action and clinical efficacy. Curr Atheroscler Rep. 2004;6:148–157. doi: 10.1007/s11883-004-0104-8
   PubMedGoogle Scholar
• Laville N, Ait-Aissa S, Gomez E, Casellas C, Porcher JM. Effects of human pharmaceuticals on cytotoxicity, EROD activity and ROS production in fish hepatocytes. Toxicology. 2004;196:41–55. doi: 10.1016/j.tox.2003.11.002
   PubMed Web of Science ®Google Scholar
• Batt AL, Kim S, Aga DS. Comparison of the occurrence of antibiotics in four full-scale wastewater treatment plants with varying designs and operations. Chemosphere. 2007;68:428–435. doi: 10.1016/j.chemosphere.2007.01.008
   PubMed Web of Science ®Google Scholar
• Ferrari B, Paxeus N, Lo Giudice R, Pollio A, Garric J. Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac. Ecotoxicol Environ Saf. 2003;55:359–370. doi: 10.1016/S0147-6513(02)00082-9
   PubMed Web of Science ®Google Scholar
• Brain RA, Johnson DJ, Richards SM, Sanderson H, Sibley PK, Solomon KR. Effects of 25 pharmaceutical compounds to Lemna gibba using a seven-day static-renewal test. Environ Toxicol Chem. 2004;23:371–382. doi: 10.1897/02-576
   PubMed Web of Science ®Google Scholar
• Brooks BW, Foran CM, Richards SM, Weston J, Turner PK, Stanley JK, Solomon KR, Slattery M, La Point TW. Aquatic ecotoxicology of fluoxetine. Toxicol Lett. 2003;142: 169–183. doi: 10.1016/S0378-4274(03)00066-3
   PubMed Web of Science ®Google Scholar
• Brooks BW, Turner PK, Stanley JK, Weston JJ, Glidewell EA, Foran CM, Slattery M, La Point TW, Huggett DB. Waterborne and sediment toxicity of fluoxetine to select organisms. Chemosphere. 2003;52:135–142. doi: 10.1016/S0045-6535(03)00103-6
   PubMed Web of Science ®Google Scholar
• Cleuvers M. Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects. Toxicol Lett. 2003;142:185–194. doi: 10.1016/S0378-4274(03)00068-7
   PubMed Web of Science ®Google Scholar
• Eguchi K, Nagase H, Ozawa M, Endoh YS, Goto K, Hirata K, Miyamoto K, Yoshimura H. Evaluation of antimicrobial agents for veterinary use in the ecotoxicity test using microalgae. Chemosphere. 2004;57:1733–1738. doi: 10.1016/j.chemosphere.2004.07.017
   PubMed Web of Science ®Google Scholar
• Farre ML, Ferrer I, Ginebreda A, Figueras M, Olivella L, Tirapu L, Vilanova M, Barcelo D. Determination of drugs in surface water and wastewater samples by liquid chromatography-mass spectrometry: methods and preliminary results including toxicity studies with Vibrio fischeri. J Chromatogr A. 2001;938:187–197. doi: 10.1016/S0021-9673(01)01154-2
   PubMed Web of Science ®Google Scholar
• Ferrari B, Mons R, Vollat B, Fraysse B, Paxeus N, Lo Giudice R, Pollio A, Garric J. Environmental risk assessment of six human pharmaceuticals: are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment? Environ Toxicol Chem. 2004;23:1344–1354. doi: 10.1897/03-246
   PubMed Web of Science ®Google Scholar
• Halling-Sorensen B, Lutzhoft HC, Andersen HR, Ingerslev F. Environmental risk assessment of antibiotics: comparison of mecillinam, trimethoprim and ciprofloxacin. J Antimicrob Chemother. 2000;46(Suppl 1):53–58; discussion 63–65. doi: 10.1093/jac/46.suppl_1.53
   Web of Science ®Google Scholar
• Halling-Sorensen B, Nors Nielsen S, Lanzky PF, Ingerslev F, Holten Lutzhoft HC, Jorgensen SE. Occurrence, fate and effects of pharmaceutical substances in the environment – a review. Chemosphere. 1998;36:357–393. doi: 10.1016/S0045-6535(97)00354-8
   PubMed Web of Science ®Google Scholar
• Henschel KP, Wenzel A, Diedrich M, Fliedner A. Environmental hazard assessment of pharmaceuticals. Regul Toxicol Pharmacol. 1997;25:220–225. doi: 10.1006/rtph.1997.1102
   PubMed Web of Science ®Google Scholar
• Huggett DB, Brooks BW, Peterson B, Foran CM, Schlenk D. Toxicity of select beta adrenergic receptor-blocking pharmaceuticals (β-blockers) on aquatic organisms. Arch Environ Contam Toxicol. 2002;43:229–235. doi: 10.1007/s00244-002-1182-7
   PubMed Web of Science ®Google Scholar
• Jos A, Repetto G, Rios JC, Hazen MJ, Molero ML, del Peso A, Salguero M, Fernandez-Freire P, Perez-Martin JM, Camean A. Ecotoxicological evaluation of carbamazepine using six different model systems with eighteen endpoints. Toxicol In Vitro. 2003;17:525–532. doi: 10.1016/S0887-2333(03)00119-X
   PubMed Web of Science ®Google Scholar
• Knoll Pharmaceuticals. BASF Pharma safety data sheet: ibuprofen. Nottingham, England: Knolls Pharmaceuticals; 1995.
   Google Scholar
• Marking LL, Howe GE, Crowther JR. Toxicity of erythromycin, oxytetracycline and tetracycline administered to lake trout in water baths by injection or by feeding. Prog Fish Cult. 1988;50:197–201. doi: 10.1577/1548-8640(1988)050<0197:TOEOAT>2.3.CO;2
   Web of Science ®Google Scholar
• Yu J, Bouwer E, Coelhan M. Occurrence and biodegradability studies of selected pharmaceuticals and personal care products in sewage effluent. Agric Water Manage. 2006;86:72–80. doi: 10.1016/j.agwat.2006.06.015
   Web of Science ®Google Scholar
• Comeau F, Surette C, Brun GL, Losier R. The occurrence of acidic drugs and caffeine in sewage effluents and receiving waters from three coastal watersheds in Atlantic Canada. Sci Total Environ. 2008;396:132–146. doi: 10.1016/j.scitotenv.2008.02.031
   PubMed Web of Science ®Google Scholar
• Gomez MJ, Martinez Bueno MJ, Lacorte S, Fernandez-Alba AR, Aguera A. Pilot survey monitoring pharmaceuticals and related compounds in a sewage treatment plant located on the Mediterranean coast. Chemosphere. 2007;66: 993–1002. doi: 10.1016/j.chemosphere.2006.07.051
   PubMed Web of Science ®Google Scholar
• Lee HB, Peart TE, Svoboda ML. Determination of endocrine-disrupting phenols, acidic pharmaceuticals, and personal-care products in sewage by solid-phase extraction and gas chromatography-mass spectrometry. J Chromatogr A. 2005;1094:122–129. doi: 10.1016/j.chroma.2005.07.070
   PubMed Web of Science ®Google Scholar
• Miao XS, Yang JJ, Metcalfe CD. Carbamazepine and its metabolites in wastewater and in biosolids in a municipal wastewater treatment plant. Environ Sci Technol. 2005;39:7469–7475. doi: 10.1021/es050261e
   PubMed Web of Science ®Google Scholar
• Health Canada. Drug product database. Ottawa, Ontario: Health Canada; 2006.
   Google Scholar
• Sosiak AJ, Hebben T. A preliminary survey of pharmaceuticals and endocrine disrupting compounds in treated municipal wastewaters and receiving rivers of Alberta. Edmonton, Alberta, Canada: Alberta Environment, Environmental Monitoring and Evaluation Branch; 2005.
   Google Scholar
• Watkinson AJ, Murby EJ, Kolpin DW, Costanzo SD. The occurrence of antibiotics in an urban watershed: from wastewater to drinking water. Sci Total Environ. 2009;407:2711–2723. doi: 10.1016/j.scitotenv.2008.11.059
   PubMed Web of Science ®Google Scholar
• Hao C, Lissemore L, Nguyen B, Kleywegt S, Yang P, Solomon K. Determination of pharmaceuticals in environmental waters by liquid chromatography/electrospray ionization/tandem mass spectrometry. Anal Bioanal Chem. 2006;384:505–513. doi: 10.1007/s00216-005-0199-y
   PubMed Web of Science ®Google Scholar
• Lissemore L, Hao C, Yang P, Sibley PK, Mabury S, Solomon KR. An exposure assessment for selected pharmaceuticals within a watershed in Southern Ontario. Chemosphere. 2006;64:717–729. doi: 10.1016/j.chemosphere.2005.11.015
   PubMed Web of Science ®Google Scholar
• Ontario Ministry of the Environment. Survey of the occurrence of pharmaceuticals and other emerging contaminants in untreated source and finished drinking water in Ontario. Toronto, Ontario: Ontario Ministry of the Environment; 2010.
   Google Scholar
• Kuchta SL, Cessna AJ. Fate of lincomycin in snowmelt runoff from manure-amended pasture. Chemosphere. 2009; 76:439–446. doi: 10.1016/j.chemosphere.2009.03.069
   Google Scholar
• Hemels ME, Koren G, Einarson TR. Increased use of antidepressants in Canada: 1981–2000. Ann Pharmacother. 2002; 36:1375–1379.
   Google Scholar
• DeVane CL. Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors. Cell Mol Neurobiol. 1999;19:443–466. doi: 10.1023/A:1006934807375
   PubMedGoogle Scholar
• Metcalfe CD, Chu S, Judt C, Li H, Oakes KD, Servos MR, Andrews DM. Antidepressants and their metabolites in municipal wastewater, and downstream exposure in an urban watershed. Environ Toxicol Chem. 2010;29:79–89. doi: 10.1002/etc.27
   PubMed Web of Science ®Google Scholar
• Lajeunesse A, Gagnon C, Sauve S. Determination of basic antidepressants and their N-desmethyl metabolites in raw sewage and wastewater using solid-phase extraction and liquid chromatography-tandem mass spectrometry. Anal Chem. 2008;80:5325–5333. doi: 10.1021/ac800162q
   PubMed Web of Science ®Google Scholar
• Albani F, Riva R, Baruzzi A. Carbamazepine clinical pharmacology: a review. Pharmacopsychology 1995;28: 235–244. doi: 10.1055/s-2007-979609
   Google Scholar
• Israel M, Beaudry P. Carbamazepine in psychiatry: a review. Can J Psychiatry. 1988;33:577–584.
   Google Scholar
• Lertratanangkoon K, Horning MG. Metabolism of carbamazepine. Drug Metab Dispos. 1982;10:1–10.
   PubMed Web of Science ®Google Scholar
• Miao XS, Metcalfe CD. Determination of carbamazepine and its metabolites in aqueous samples using liquid chromatography-electrospray tandem mass spectrometry. Anal Chem. 2003;75:3731–3738. doi: 10.1021/ac030082k
   PubMed Web of Science ®Google Scholar
• Andreozzi R, Marotta R, Pinto G, Pollio A. Carbamazepine in water: persistence in the environment, ozonation treatment and preliminary assessment on algal toxicity. Water Res. 2002;36:2869–2877. doi: 10.1016/S0043-1354(01)00500-0
   PubMed Web of Science ®Google Scholar
• Lee HB, Sarafin K, Peart TE. Determination of β-blockers and β2-agonists in sewage by solid-phase extraction and liquid chromatography-tandem mass spectrometry. J Chromatogr A. 2007;1148:158–167. doi: 10.1016/j.chroma.2007.03.024
   PubMed Web of Science ®Google Scholar
• Nikolai LN, McClure EL, Macleod SL, Wong CS. Stereoisomer quantification of the β-blocker drugs atenolol, metoprolol, and propranolol in wastewaters by chiral high-performance liquid chromatography-tandem mass spectrometry. J Chromatogr A. 2006;1131:103–109. doi: 10.1016/j.chroma.2006.07.033
   PubMed Web of Science ®Google Scholar
• Scheurer M, Ramil M, Metcalfe CD, Groh S, Ternes TA. The challenge of analyzing β-blocker drugs in sludge and wastewater. Anal Bioanal Chem. 2010;396:845–856. doi: 10.1007/s00216-009-3225-7
   PubMed Web of Science ®Google Scholar
• Winkler M, Lawrence JR, Neu TR. Selective degradation of ibuprofen and clofibric acid in two model river biofilm systems. Water Res. 2001;35:3197–3205. doi: 10.1016/S0043-1354(01)00026-4
   PubMed Web of Science ®Google Scholar
• Lee HB, Peart TE, Svoboda ML, Backus S. Occurrence and fate of rosuvastatin, rosuvastatin lactone, and atorvastatin in Canadian sewage and surface water samples. Chemosphere. 2009;77:1285–1291. doi: 10.1016/j.chemosphere.2009.09.068
   PubMed Web of Science ®Google Scholar
• Thomas DJ, Tyrrel SF, Smith R, Farrow S. Bioassays for the evaluation of landfill leachate toxicity. J Toxicol Environ Health B Crit Rev. 2009;12:83–105. doi: 10.1080/10937400802545292
   PubMed Web of Science ®Google Scholar